Hospira Recalls
167 recalls on record in the United States
Hospira Inc., A Pfizer Company recalls Plum 360 Infusion Pump, Software Version 15.02. The infusion
Depleted Battery alarm shows instead of Replace Battery. On battery power, ongoing therapy stops, alarms show and sound, pump shuts down after 3 minutes. On AC power, the pump reboots (takes about 25 seconds). Therapy can resume. AC power interruption of 3-7 seconds prompts an incorrect E323 alarm, ongoing therapy stop, and pump reboot. Longer power loss results in battery power operation.
View recall details →
Hospira Inc. recalls Minibore Extension Set, 59 Inch with Spin Lock Collar, Non-D
Hospira, Inc. is voluntarily recalling one lot of list 14699-28, Minibore Extension Set, 59 inch with Spin Lock Collar, Non-DEHP, identified above due to a confirmed customer report of an occlusion of solvent in the male luer lock. This occlusion has the potential to prevent the set from being primed for use and cause a delay in therapy.
View recall details →
HOSPIRA INC, LAKE FOREST recalls Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.
Presence of Particulate Matter; Potential for particulate matter on the syringe plunger.
View recall details →
Hospira Inc. A Pfizer Company recalls Labetalol Hydrochloride Injection, USP, 100 mg/ 20 mL (5 mg/
Defective Container: Cracked glass at the rim surface of glass vials, covered by the stopper and crimp seal.
View recall details →
HOSPIRA INC, LAKE FOREST recalls Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10
Presence of Particulate Matter: Silicone oil
View recall details →
HOSPIRA INC, LAKE FOREST recalls Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10
Presence of Particulate Matter: Silicone oil
View recall details →
HOSPIRA INC, LAKE FOREST recalls Hydromorphone Hydrochloride Injection, USP, 50 mg/5 mL (10 m
Presence of Particulate Matter: Silicone oil
View recall details →
Hospira a Pfizer Company recalls 8.4% Sodium Bicarbonate Inj., USP 50 mL Single-dose, 50 mEq
Lack of Sterility Assurance
View recall details →
Hospira a Pfizer Company recalls Potassium Phosphates Inj., USP, 45 mM (3 mM P/mL) Also conta
Lack of Sterility Assurance
View recall details →
Hospira a Pfizer Company recalls Neut Sodium Bicarbonate 4% (2.4 mEq) Additive Solution 5 mL
Lack of Sterility Assurance
View recall details →
Hospira a Pfizer Company recalls Succinylcholine Chloride Injection, USP 200 mg (20 mg/mL) Qu
Lack of Sterility Assurance
View recall details →
Hospira Inc., A Pfizer Company recalls Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 5 mL Single
Failed Impurities/Degradation Specifications; out of specification result for denitroquinoline-related impurity during three month time point
View recall details →
Hospira Inc., A Pfizer Company recalls Levophed norepinephrine bitartrate, injection, USP, 4 mg /4
GMP Deviation; A foreign stopper was observed during packaging of a lot of product.
View recall details →
Hospira Inc. recalls Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL
Presence of Particulate Matter: human hair found within an internal sample syringe.
View recall details →
Hospira Inc., A Pfizer Company recalls Vancomycin Hydrochloride for Injection, USP, 10 grams, Pharm
Presence of Particulate Matter: A hair was found stuck to the stopper of inside a single vial. The hair came in contact with the reconstituted drug product.
View recall details →
Hospira Inc., A Pfizer Company recalls METRONIDazole Injection, USP 500 mg (5 mg/mL) in 100 mL Sing
Lack of Sterility Assurance: customer report of leaking bag
View recall details →
Hospira Inc., A Pfizer Company recalls Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packa
Presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial.
View recall details →
Hospira Inc. recalls 5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Sing
Failed Stability Specifications: The recalled lots did not meet the specification for color and pH throughout shelf life.
View recall details →
Hospira Inc. recalls Fentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Sing
Lack of Assurance of Sterility: Complaints of broken tips on the ampules.
View recall details →
Hospira Inc., A Pfizer Company recalls Marcaine 0.25% (bupivacaine HCl) injection, USP, 125 mg/50 m
Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal allowing water to ingress and dilute the product causing it to be less than the labeled potency.
View recall details →
Hospira Inc., A Pfizer Company recalls Marcaine 0.5% (bupivacaine HCl) injection, USP, 250 mg/50 mL
Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal allowing water to ingress and dilute the product causing it to be less than the labeled potency.
View recall details →
Hospira Inc. recalls DOBUTamine Injection, USP 250 mg/20 mL, 20 mL Vial, For IV U
Discoloration: Firm received complaints of product discoloration and particulates.
View recall details →
Hospira Inc. recalls Diazepam Injection USP 10mg/2mL (5 mg/mL, 2 mL), Rx only, H
Crystallization: Product contains particulate identified to be crystallized active ingredient.
View recall details →
Hospira Inc. recalls Magnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 m
Presence of Particulate Matter: Confirmed customer complaint for the presence of particulate matter.
View recall details →
Hospira Inc. recalls Vancomycin Hydrochloride for Injection, USP, 10 g, 100 mL vi
Presence of Particulate Matter: Cardboard
View recall details →
Hospira Inc. recalls 8.4% Sodium Bicarbonate Injection, USP 50mEq (1mEq/mL), 4.2
Presence of Particulate Matter: particulate matter identified as an insect in one vial.
View recall details →
Hospira Inc. recalls Magnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 m
Failed pH Specifications: Confirmed high out of specification (OOS) results for pH.
View recall details →
Hospira Inc. recalls Quelicin (Succinylcholine Chloride) Injection, USP 200 mg. (
Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for the lot number and/or expiration date to be faded or missing from the primary label on the glass vial.
View recall details →
Hospira Inc. recalls Dextrose Injection, USP, 20%, Packaged as 500 mL in 1000 mL
Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.
View recall details →
Hospira Inc. recalls Mannitol I.V., 20%, USP (20 g/ 100 mL), Packaged in 250 mL B
Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.
View recall details →
Showing 30 of 167 recalls. See all →